Impact of cancer diagnosis on persistence of oral antidiabetic drugs
Diabetes Research and Clinical Practice Mar 15, 2018
Louis L, et al. - The effects of cancer occurrence on the persistence of oral antidiabetic drugs (OAD) were determined. A higher risk of non-persistence for lung cancer via subgroup analyses according to cancer localization was shown. A correlation existed between cancer diagnosis and OAD non-persistence.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
